These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7682382)

  • 21. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
    Iqbal J; Rab A; Perlmann P; Berzins K
    Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.
    Alonso PL; Lopez MC; Bordmann G; Smith TA; Aponte JJ; Weiss NA; Urassa H; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Thomas MC; Oettli A; Hurt N; Hayes R; Kilama WL; Tanner M
    Parasite Immunol; 1998 Feb; 20(2):63-71. PubMed ID: 9572049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
    Rosas JE; Pedraz JL; Hernández RM; Gascón AR; Igartua M; Guzmán F; Rodríguez R; Cortés J; Patarroyo ME
    Vaccine; 2002 Mar; 20(13-14):1707-10. PubMed ID: 11906756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum.
    Herrera S; Herrera MA; Corredor A; Rosero F; Clavijo C; Guerrero R
    Am J Trop Med Hyg; 1992 Nov; 47(5):682-90. PubMed ID: 1449209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
    Hui GS; Nikaido C; Hashiro C; Kaslow DC; Collins WE
    Infect Immun; 1996 May; 64(5):1502-9. PubMed ID: 8613353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax.
    Kumar N; Folgar JP; Lubega P
    Am J Trop Med Hyg; 1992 Oct; 47(4):422-8. PubMed ID: 1279995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of antibodies to a 70 kDa Plasmodium falciparum exoantigen in malarious subjects using synthetic peptides.
    Toebe CS; Montenegro-James S; Noya O; Riggione F; James MA
    Trop Med Parasitol; 1993 Mar; 44(1):1-4. PubMed ID: 8516626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WITHDRAWN: Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine.
    Tamborrini M; Mueller MS; Stoffel SA; Westerfeld N; Vogel D; Boato F; Zurbriggen R; Robinson JA; Pluschke G
    Malar J; 2009 Dec; 8():314. PubMed ID: 20042100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
    Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and antigenicity of the N-term repeat amino acid sequence of the Plasmodium falciparum P126 antigen.
    Banic DM; Bossus M; Delplace P; Tartar A; Gras-Masse H; Conseil V; Mazingue C; de Taisne C; Camus D
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():159-62. PubMed ID: 1343686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite.
    von Brunn A; Früh K; Müller HM; Zentgraf HW; Bujard H
    Vaccine; 1991 Jul; 9(7):477-84. PubMed ID: 1716808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.